A versatile ligation-independent cloning method suitable for high-throughput expression screening applications
Nicholas S. Berrow(Institute for Research in Biomedicine), Raymond J. Owens(University of Oxford)
Cited by 571
Related Papers
A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19
|Nature Communications|2021|154
Site-specific attachment to recombinant antibodies via introduced surface cysteine residues
|Protein Engineering Design and Selection|1990|66
Isotype choice for chimeric antibodies affects binding properties.
|Journal of Biological Chemistry|1994|51